Appili Therapeutics Inc (APLIF PINK) stock market data APIs
$0.01
0(0%)
as of July 20, 2026
Try our APIs with
free plan!
Appili Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of treatments targeting unmet needs in infectious diseases in the United States and Canada. The company offers LIKMEZ (ATI-1501), a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial and protozoal infections. It also develops ATI-1801, a topical formulation of paromomycin in a Phase III trial for the treatment of cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine in preclinical trials for the prevention of Francisella tularensis infection. The company has a collaboration with Vitalex Biosciences to advance VXV-01, a dual-antigen vaccine targeting invasive Candida infections. Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.
Prev. Close
0.01
Open
0.01
High
0.01
Low
0.01
52 wk Range
0.008-0.03
Market Cap
1 324 K
Shares Outstanding
132 M
Revenue
244 K
EPS
-0.0058
Beta
-0.207
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Appili Therapeutics Inc data using free add-ons & libraries
Get Appili Therapeutics Inc Fundamental Data
Appili Therapeutics Inc Fundamental data includes:
- Net Revenue: 244 K
- EBITDA: -6 516 761
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-07-01
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Appili Therapeutics Inc News
New
Appili Therapeutics Q3 Loss Increases
(RTTNews) - Appili Therapeutics (APLIF) reported Loss for its third quarter of -C$0.95 million The company's earnings totaled -C$0.95 million, or -C$0.01 per share. This compares with -C$0.52 millio...
Appili Therapeutics Inc. GAAP EPS of -$0.01
* Appili Therapeutics Inc. press release [https://seekingalpha.com/pr/20307570-appili-therapeutics-reports-financial-and-operational-results-for-second-quarter-of-fiscal] (APLI:CA [https://seekingal...
Appili Therapeutics Q2 Sales Increase
(RTTNews) - Appili Therapeutics (APLIF) revealed Loss for second quarter of -C$0.99 million The company's bottom line came in at -C$0.99 million, or -C$0.01 per share. This compares with -C$0.74 mil...
Appili Therapeutics Announces New Late-Stage Clinical Program ATI-1801 to Treat Cutaneous Leishmaniasis
Topical formulation of paromomycin ATI-1801 already shown to be safe and effective against the disfiguring disease in Phase 3 study ATI-1801 may be eligible for tropical disease priority review vouch...
Get Appili Therapeutics Inc fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
